Perioperative use of clevidipine: A systematic review and meta-analysis

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Espinosa, Angel ^a   Ripollés Melchor, Javier ^b   Casans Francés, Rubén ^c   Abad Gurumeta, Alfredo ^d   Bergese, Sergio D ^e   Zuleta Alarcon, Alix ^e   López Timoneda, Francisco ^b   Calvo Vecino, José María ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CLEVIDIPINE; ESMOLOL; ESTERASE; GLYCERYL TRINITRATE; LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM; PLACEBO; CALCIUM CHANNEL BLOCKING AGENT; PYRIDINE DERIVATIVE;

ATRIAL FIBRILLATION; DRUG CHOICE; DRUG EFFICACY; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG TREATMENT FAILURE; DRUG USE; HUMAN; HYPERTENSION; META ANALYSIS; METHODOLOGY; PERIOPERATIVE PERIOD; REVIEW; SYSTEMATIC REVIEW; THROMBOPHLEBITIS; UNSPECIFIED SIDE EFFECT; BLOOD PRESSURE; DRUG EFFECTS; FACTUAL DATABASE; PATHOLOGY;

ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DATABASES, FACTUAL; HUMANS; HYPERTENSION; PERIOPERATIVE CARE; PYRIDINES;

EID: 84962172875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150625     Document Type: Review

References (40)

1. Kurnutala L, Sandhu G., Vandse R., Soghomonyan S., and Bergese SD. Innovative approaches to the management of acute arterial hypertension-clevidipine butyrate. Int J Anesthesiol. 2013;1-4(2013):18-24.
2. Zuleta-Alarcon A, Castellon-Larios K, Bergese S. [The role of clevidipine in hypertension management: clinical results]. Rev Esp Anestesiol Reanim. 2014;61(10):557-64. doi: 10.1016/j.redar.2014.06.006 PMID: 25236947.
3. Pollack CV Jr, Rees CJ. ACuTE CARE EVAluATIoN ANd MANAGEMENT. Emergency Medicine Cardiac Research and Education Group. 2008;3.
4. Awad AS, Goldberg ME. Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review. Vasc Health Risk Manag. 2010;6:457-64. PMID: 20730061; PubMed Central PMCID: PMCPMC2922306.
5. Aronson S, Dyke CM, Levy JH, Cheung AT, Lumb PD, Avery EG, et al. Does perioperative systolic blood pressure variability predict mortality after cardiac surgery? An exploratory analysis of the ECLIPSE trials. Anesth Analg. 2011;113(1):19-30. doi: 10.1213/ANE.0b013e31820f9231 PMID: 21346163.
6. Erickson AL, De Grado JR, Fanikos JR. Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension. Pharmacotherapy. 2010;30(5):515-28. doi: 10. 1592/phco.30.5.515 PMID: 20412001.
7. Van Der Stroom JG, Van Wezel HB, Langemeijer JJ, Korsten HH, Kooyman J, Van Der Starre PJ, et al. A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery. J Cardiothorac Vasc Anesth. 1997;11(6):729-36. PMID: 9327314.
8. Prlesi L, Cheng-Lai A. Clevidipine: a novel ultra-short-acting calcium antagonist. Cardiol Rev. 2009;17(3):147-52. doi: 10.1097/CRD.0b013e31819fe23c PMID: 19384089.
9. Eisenberg MJ, Brox A, Bestawros AN. Calcium channel blockers: an update. Am J Med. 2004;116(1):35-43. PMID: 14706664.
10. Bergese SD, Puente EG. Clevidipine butyrate: a promising new drug for the management of acute hypertension. Expert Opin Pharmacother. 2010;11(2):281-95. doi: 10.1517/14656560903499293 PMID: 20088748.
11. Tulman DB, Stawicki SP, Papadimos TJ, Murphy CV, Bergese SD. Advances in management of acute hypertension: a concise review. Discov Med. 2012;13(72):375-83. PMID: 22642919; PubMed Central PMCID: PMCPMC3727280.
12. Levy JH, Mancao MY, Gitter R, Kereiakes DJ, Grigore AM, Aronson S, et al. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg. 2007;105(4):918-25, table of contents. doi: 10.1213/01.ane. 0000281443.13712.b9 PMID: 17898366.
13. Singla N, Warltier DC, Gandhi SD, Lumb PD, Sladen RN, Aronson S, et al. Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebocontrolled trial. Anesth Analg. 2008;107(1):59-67. doi: 10.1213/ane.0b013e3181732e53 PMID: 18635468.
14. Aronson S, Dyke CM, Stierer KA, Levy JH, Cheung AT, Lumb PD, et al. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107(4):1110-21. doi: 10.1213/ane. 0b013e31818240db PMID: 18806012.
15. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-12. doi: 10.1016/j. jclinepi.2009.06.005 PMID: 19631508.
16. Higgins J. Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0. The Cochrane Collaboration, 2011. 2013.
17. Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol. 2014;14:120. doi: 10.1186/1471-2288-14-120 PMID: 25416419; PubMed Central PMCID: PMCPMC4251848.
18. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1 PMID: 25554246; PubMed Central PMCID: PMCPMC4320440.
19. Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
20. Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw. 2012;49(5):1-15.
21. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. PMID: 3802833.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60. doi: 10.1136/bmj.327.7414.557 PMID: 12958120; PubMed Central PMCID: PMCPMC192859.
23. Neumann I, Pantoja T, Penaloza B, Cifuentes L, Rada G. [The GRADE system: a change in the way of assessing the quality of evidence and the strength of recommendations]. Rev Med Chil. 2014;142(5):630-5. doi: 10.4067/S0034-98872014000500012 PMID: 25427021.
24. Jakobsen JC, Gluud C, Winkel P, Lange T, Wetterslev J. The thresholds for statistical and clinical significance-a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol. 2014;14:34. doi: 10.1186/1471-2288-14-34 PMID: 24588900; PubMed Central PMCID: PMCPMC4015863.
25. Levy JH. The ideal agent for perioperative hypertension and potential cytoprotective effects. Acta Anaesthesiol Scand Suppl. 1993;99:20-5. PMID: 8480502.
26. Desai RG, Muntazar M, Goldberg ME. Strategies for managing perioperative hypertension. Curr Hypertens Rep. 2009;11(3):173-7. PMID: 19442325.
27. Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68(3):283-97. PMID: 18257607.
28. Padilla Ramos A, Varon J. Current and newer agents for hypertensive emergencies. Curr Hypertens Rep. 2014;16(7):450. doi: 10.1007/s11906-014-0450-z PMID: 24863753.
29. Cleviprex (clevidipine butyrate) [package insert]. Parsipanny NT, 2008 MC.
30. Ericsson H, Schwieler J, Lindmark BO, Lofdahl P, Thulin T, Regardh CG. Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients. Chirality. 2001;13(3):130-4. doi: 10.1002/1520-636X (2001) 13:3<130::AIDCHIR1009> 3.0. CO;2-2 PMID: 11270321.
31. Ericsson H, Tholander B, Regardh CG. In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man. Eur J Pharm Sci. 1999;8(1):29-37. PMID: 10072476.
32. Ericsson H, Fakt C, Jolin-Mellgard A, Nordlander M, Sohtell L, Sunzel M, et al. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br J Clin Pharmacol. 1999;47(5):531-8. PMID: 10336577; PubMed Central PMCID: PMCPMC2014189.
33. Ericsson H, Fakt C, Hoglund L, Jolin-Mellgard A, Nordlander M, Sunzel M, et al. Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. Eur J Clin Pharmacol. 1999;55(1):61-7. PMID: 10206087.
34. Schwieler JH, Ericsson H, Lofdahl P, Thulin T, Kahan T. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. J Cardiovasc Pharmacol. 1999;34(2):268-74. PMID: 10445679.
35. Murphy Cv, Brower KI. Safety and Efficacy of Intravenous Clevidipine for the Perioperative Control of Acute Hypertension. Clinical Medicine Insights Therapeutics. 2011;3.
36. Nordlander M, Sjoquist PO, Ericsson H, Ryden L. Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev. 2004;22(3):227-50. PMID: 15492770.
37. Hersey SL, O'Dell NE, Lowe S, Rasmussen G, Tobias JD, Deshpande JK, et al. Nicardipine versus nitroprusside for controlled hypotension during spinal surgery in adolescents. Anesth Analg. 1997;84(6):1239-44. PMID: 9174299.
38. Kieler-Jensen N, Jolin-Mellgard A, Nordlander M, Ricksten SE. Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. Acta Anaesthesiol Scand. 2000;44(2):186-93. PMID: 10695913.
39. Powroznyk AV, Vuylsteke A, Naughton C, Misso SL, Holloway J, Jolin-Mellgard A, et al. Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery. Eur J Anaesthesiol. 2003;20(9):697-703. PMID: 12974590.
40. Merry AF, Avery EG, Nussmeier NA, Playford HR, Warman GR, Wang Y, et al. Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized doubleblind study. Can J Anaesth. 2014;61(5):398-406. doi: 10.1007/s12630-014-0131-z PMID: 24700403.